Literature DB >> 9207213

Regulation of osteoclastic bone resorption by glucose.

J P Williams1, H C Blair, J M McDonald, M A McKenna, S E Jordan, J Williford, R W Hardy.   

Abstract

Osteoclasts degrade bone by pumping molar quantities of HCl to dissolve the calcium salts of bone, an energy intensive process evidently supported by abundant mitochondria. This is the first study to directly examine the ability of various metabolites to serve as potential energy sources for osteoclastic bone resorption. Glucose, and to a lesser extent lactate, supported osteoclastic bone degradation. However, fatty acids (palmitate, myristate and stearate), essential amino acids plus 20 mM alanine, or ketone bodies (acetoacetate, beta-hydroxybutyrate and alpha-ketoglutarate) did not support bone degradation. Resorption declined to 10-30% of glucose controls when fatty acids or ketoacids were substituted for glucose. Resorption was glucose concentration dependent, with maximal activity at approximately 7 mM (K(M) approximately 3 mM). Glucose transport was linear for approximately 15 minutes, specific for D-glucose, and inhibited by cytochalasin B. Osteoclasts cultured on bone transported glucose at almost twice the rate of those off bone (Vmax 23 versus 13 nmols/mg/min, respectively) and medium acid accumulation paralleled glucose uptake, while the K(M) was unchanged. We conclude that glucose is the principal energy source required for bone degradation. Further, characteristics of glucose transport are consistent with the hypothesis that fluctuations in serum glucose concentration are an important component in regulation of osteoclastic bone degradation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207213     DOI: 10.1006/bbrc.1997.6795

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  36 in total

Review 1.  Glucose metabolism in bone.

Authors:  Courtney M Karner; Fanxin Long
Journal:  Bone       Date:  2017-08-24       Impact factor: 4.398

Review 2.  Bone, sweet bone--osteoporotic fractures in diabetes mellitus.

Authors:  Christine Hamann; Stephan Kirschner; Klaus-Peter Günther; Lorenz C Hofbauer
Journal:  Nat Rev Endocrinol       Date:  2012-01-17       Impact factor: 43.330

3.  Hyperglycemia induced and intrinsic alterations in type 2 diabetes-derived osteoclast function.

Authors:  D L Catalfamo; T M Britten; D L Storch; N L Calderon; H L Sorenson; S M Wallet
Journal:  Oral Dis       Date:  2013-04       Impact factor: 3.511

4.  Augmented LPS responsiveness in type 1 diabetes-derived osteoclasts.

Authors:  Dana L Catalfamo; Nadia L Calderon; Scott W Harden; Heather L Sorenson; Kathleen G Neiva; Shannon M Wallet
Journal:  J Cell Physiol       Date:  2013-02       Impact factor: 6.384

5.  Risk of fractures and bone abnormalities in postmenopausal women with type 2 diabetes mellitus.

Authors:  Maria Giovanna Filippella; Antongiulio Faggiano; Alberto Falchetti; Annamaria Colao; Carlo Rosa; Carlo Poti; Corrado Musso; Giulio Doveri; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2010-05

6.  Fast dissolving glucose porogens for early calcium phosphate cement degradation and bone regeneration.

Authors:  Eline-Claire Grosfeld; Brandon T Smith; Marco Santoro; Irene Lodoso-Torrecilla; John A Jansen; Dietmar Jo Ulrich; Anthony J Melchiorri; David W Scott; Antonios G Mikos; Jeroen J J P van den Beucken
Journal:  Biomed Mater       Date:  2020-02-17       Impact factor: 3.715

7.  Bone metabolism and the 10-year probability of hip fracture and a major osteoporotic fracture using the country-specific FRAX algorithm in men over 50 years of age with type 2 diabetes mellitus: a case-control study.

Authors:  Harjit P Bhattoa; Ugo Onyeka; Edit Kalina; Adam Balogh; Gyorgy Paragh; Peter Antal-Szalmas; Miklos Kaplar
Journal:  Clin Rheumatol       Date:  2013-04-16       Impact factor: 2.980

8.  Spinal deformity index in patients with type 2 diabetes.

Authors:  C Di Somma; M Rubino; A Faggiano; L Vuolo; P Contaldi; N Tafuri; N Tafuto; M Andretti; S Savastano; A Colao
Journal:  Endocrine       Date:  2012-12-11       Impact factor: 3.633

Review 9.  Diabetes mellitus and osteoporosis.

Authors:  Robert Sealand; Christie Razavi; Robert A Adler
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810

10.  High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis.

Authors:  Y Wittrant; Y Gorin; K Woodruff; D Horn; H E Abboud; S Mohan; S L Abboud-Werner
Journal:  Bone       Date:  2008-02-29       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.